Examining the role of insurance in inter-facility transfer for patients with ST-elevation myocardial infarction

探讨保险在 ST 段抬高型心肌梗死患者跨机构转运中的作用

基本信息

  • 批准号:
    9813173
  • 负责人:
  • 金额:
    $ 12.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT In the U.S., nearly 500,000 patients suffer an ST-elevation myocardial infarction (STEMI) each year, the majority of which initially present to emergency departments (EDs). More than 60% of U.S. hospitals do not have have the capabilities to perform the primary percutaneous coronary intervention (PCI), the preferred strategy for myocardial reperfusion. Thus, patients must be transferred to capable facilities which are associated with delays for nearly 90% of patients and worse patient outcomes. Our research team has identified that insurance status is a key non-medical predictor of increased transfer. Patients with STEMI who lack insurance presenting to the ED were 60% more likely to be transferred compared with patients with any form of insurance. Two potential reasons for this finding include uninsured patients presenting to facilities without PCI capabilities and alternatively, uninsured patients being transferred unnecessarily from facilities that have PCI capabilities. The objective of this study is to identify the underlying mechanism resulting in disproportionately higher inter- facility transfer rates for uninsured patients with STEMI. Whether the uninsured have diminished access to PCI-capable facilities, or they are transferred from PCI-capable facilities, either explanation has important policy implications for reducing this disparity in access to optimal management of this time-sensitive emergency medical condition. We have identified an established dataset, the Office of Statewide Health Planning and Development (OSHPD) dataset in California which has detailed ED visit data which will allow us identify the underlying mechanism of higher transfer rates. Combined with important health policy changes broadening health insurance access including the early expansion of Medi-Cal at the county-level, this provides an important natural experiment to understand how insurance access affects access to care for time- sensitive emergencies like STEMI. This proposal describes an analysis of the existing datasets to understand the mechanism of more patients with STEMI who lack insurance and are transferred at a much higher rate. The Specific Aims are: 1) Describe the incidence, longitudinal trends, and transfer status of patients with STEMI presenting to California EDs by facility PCI capability; 2) Use Medicaid expansion in California to estimate the relationship between insurance status and transfer of patients presenting to California EDs with STEMI, and assess whether PCI capability modifies these relationships. We have assembled a multidisciplinary team of experts in cardiology, emergency medicine, health policy, health services research, biostatistics, epidemiology, and systems science. We anticipate that the knowledge gained from this will inform policy makers seeking to understand disparities in care, and to understand whether insurance expansion is a potential intervention to address these disparities.
项目概要/摘要 在美国,每年有近 500,000 名患者患有 ST 段抬高型心肌梗死 (STEMI) 其中大部分最初提交给急诊科 (ED)。超过60%的美国医院没有 有能力进行初次经皮冠状动脉介入治疗(PCI),首选 心肌再灌注策略。因此,必须将患者转移到有能力的设施,这些设施 与近 90% 的患者的延误和患者预后较差有关。我们的研究团队有 确定保险状况是转移增加的关键非医疗预测因素。 STEMI 患者 与患者相比,缺乏保险到急诊室就诊的患者转院的可能性高出 60% 任何形式的保险。这一发现的两个潜在原因包括未投保的患者就诊 没有 PCI 能力的设施,或者,没有保险的患者被不必要地从 具有 PCI 功能的设施。 本研究的目的是确定导致不成比例的较高交互作用的根本机制。 未投保 STEMI 患者的设施转移率。未参保者获得保险的机会是否减少 支持 PCI 的设施,或者它们是从支持 PCI 的设施转移的,任一解释都很重要 减少这种对时间敏感的最佳管理的差距的政策影响 紧急医疗状况。我们已经确定了一个已建立的数据集,即全州卫生办公室 加利福尼亚州的规划和发展 (OSHPD) 数据集包含详细的 ED 就诊数据,这将使我们能够 确定更高传输率的根本机制。结合重要的卫生政策变化 扩大医疗保险覆盖范围,包括早期将 Medi-Cal 扩大到县级,这 提供了一个重要的自然实验,以了解保险的获取如何影响获得时间护理的机会- STEMI 等敏感紧急情况。 该提案描述了对现有数据集的分析,以了解更多患者的机制 患有 STEMI 的人缺乏保险并且转院率要高得多。具体目标是: 1) 描述 向加州急诊室就诊的 STEMI 患者的发病率、纵向趋势和转移状态 设施 PCI 能力; 2) 使用加州医疗补助扩展来估计保险之间的关系 向加州急诊室就诊的 STEMI 患者的状况和转诊情况,并评估 PCI 能力 修改这些关系。 我们组建了一支由心脏病学、急诊医学、卫生政策、 卫生服务研究、生物统计学、流行病学和系统科学。我们预计知识 从中获得的信息将为政策制定者提供信息,以了解护理方面的差异,并了解是否 扩大保险范围是解决这些差异的潜在干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael J. Ward其他文献

Potentially avoidable Inter-Facility transfer from Veterans Health Administration emergency departments: A cohort study
  • DOI:
    10.1186/s12913-020-4956-6
  • 发表时间:
    2020-02-12
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Nicholas M. Mohr;Chaorong Wu;Michael J. Ward;Candace D. McNaughton;Kelly Richardson;Peter J. Kaboli
  • 通讯作者:
    Peter J. Kaboli
Endogenous pre-stimulus activity modulates category tuning in ventral temporal cortex and influences perceptual behavior
内源性刺激前活动调节腹侧颞叶皮层的类别调整并影响感知行为
  • DOI:
    10.32470/ccn.2018.1079-0
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yuanning Li;Michael J. Ward;Mark Richardson;M. G'Sell;A. Ghuman
  • 通讯作者:
    A. Ghuman
An Asymptotic Analysis of Spike Self-Replication and Spike Nucleation of Reaction-Diffusion Patterns on Growing 1-D Domains
  • DOI:
    10.1007/s11538-025-01418-0
  • 发表时间:
    2025-02-24
  • 期刊:
  • 影响因子:
    2.200
  • 作者:
    Chunyi Gai;Edgardo Villar-Sepúlveda;Alan Champneys;Michael J. Ward
  • 通讯作者:
    Michael J. Ward
Logarithmic Expansions and the Stability of Periodic Patterns of Localized Spots for Reaction–Diffusion Systems in $${\mathbb {R}}^2$$
  • DOI:
    10.1007/s00332-014-9206-9
  • 发表时间:
    2014-05-02
  • 期刊:
  • 影响因子:
    2.600
  • 作者:
    David Iron;John Rumsey;Michael J. Ward;Juncheng Wei
  • 通讯作者:
    Juncheng Wei
Synchronous oscillations for a coupled cell-bulk ODE–PDE model with localized cells on $${\mathbb {R}}^2$$
  • DOI:
    10.1007/s10665-021-10113-7
  • 发表时间:
    2021-03-14
  • 期刊:
  • 影响因子:
    1.400
  • 作者:
    Sarafa A. Iyaniwura;Jia Gou;Michael J. Ward
  • 通讯作者:
    Michael J. Ward

Michael J. Ward的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael J. Ward', 18)}}的其他基金

Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
  • 批准号:
    10749448
  • 财政年份:
    2023
  • 资助金额:
    $ 12.75万
  • 项目类别:
PORTAL: Patient Outcome Reporting Tool for emergency medicAL services
门户网站:紧急医疗服务的患者结果报告工具
  • 批准号:
    10653774
  • 财政年份:
    2021
  • 资助金额:
    $ 12.75万
  • 项目类别:
PORTAL: Patient Outcome Reporting Tool for emergency medicAL services
门户网站:紧急医疗服务的患者结果报告工具
  • 批准号:
    10475726
  • 财政年份:
    2021
  • 资助金额:
    $ 12.75万
  • 项目类别:
PORTAL: Patient Outcome Reporting Tool for emergency medicAL services
门户网站:紧急医疗服务的患者结果报告工具
  • 批准号:
    10301974
  • 财政年份:
    2021
  • 资助金额:
    $ 12.75万
  • 项目类别:
Enhancing Inter-Facility Transfer for Patients with Acute Myocardial Infarction
加强急性心肌梗死患者的机构间转运
  • 批准号:
    9198263
  • 财政年份:
    2016
  • 资助金额:
    $ 12.75万
  • 项目类别:
Enhancing Inter-Facility Transfer for Patients with Acute Myocardial Infarction
加强急性心肌梗死患者的机构间转运
  • 批准号:
    9405604
  • 财政年份:
    2016
  • 资助金额:
    $ 12.75万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 12.75万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了